Frequency of MYD88 and CD79B mutations, and MGMT methylation in primary central nervous system diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

Frequency of MYD88 and CD79B mutations, and MGMT methylation in primary central nervous system diffuse large B-cell lymphoma

Published:2017-08-30 Issue:6 Volume:37 Page:509-516
ISSN:0919-6544
Container-title:Neuropathology
language:en
Short-container-title:Neuropathology

Author:

Zheng Mei¹,Perry Anamarija M.²^ORCID,Bierman Philip³,Loberiza Fausto³,Nasr Michel R.²,Szwajcer David⁴,Del Bigio Marc R.²,Smith Lynette M.⁵,Zhang Weiwei¹,Greiner Timothy C.¹

Affiliation:

1. Department of Pathology and Microbiology; University of Nebraska Medical Center; Omaha Nebraska USA

2. Department of Pathology; University of Manitoba; Winnipeg Manitoba Canada

3. Department of Internal Medicine; University of Nebraska Medical Center; Omaha Nebraska USA

4. Department of Internal Medicine; University of Manitoba; Winnipeg Manitoba Canada

5. Department of Biostatistics; University of Nebraska Medical Center; Omaha Nebraska USA

Funder

Fred & Pamela Buffett Cancer Center's National Cancer Institute Cancer Center Support Grant

Publisher

Wiley

Subject

Neurology (clinical),General Medicine,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/neup.12405/fullpdf

Reference36 articles.

1. Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: Results of a critical review of the literature;Reni;Ann Oncol,1997

2. Current and emerging pharmacotherapies for primary CNS lymphoma;Prodduturi;Clin Med Insights Oncol,2012

3. The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin's lymphoma;O'Neill;Am J Hematol,2013

4. Intravenous methotrexate as initial treatment for primary central nervous system lymphoma: Response to therapy and quality of life of patients;Guha-Thakurta;J Neurooncol,1999

5. Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma;Bierman;Hematol Oncol Clin North Am,2005

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic potential of vitreoretinal lymphoma by detection of gene mutations with NGS in 25 Chinese patients;Clinica Chimica Acta;2024-07

2. Comparative Study on the Clinicopathologic and Molecular Characteristics of Primary and Secondary Diffuse Large B-cell Lymphoma in the Central Nervous System;Anticancer Research;2024-06-26

3. Exome and targeted sequencing in clinical oncology- Diffuse large B-cell lymphoma as a model;Comprehensive Precision Medicine;2024

4. Uveitis masquerade syndromes: An approach to diagnosis;Clinical & Experimental Ophthalmology;2023-11-23

5. Prognostic impact of MYD88 and TP53 mutations in diffuse large B Cell lymphoma;Annals of Hematology;2023-09-02